Scientific Program ISCORT 14 27.01.15 - 31.01.15, Eilat, Israel The Annual Meeting of the Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies for their support of the 14th ISCORT Annual Meeting: Organizing Committe Platinum Sponsor Roche Pharmaceuticals (Israel) Ltd President: Prof. Ron Epelbaum Secretary: Dr. Ravit Geva Gold Sponsor Astrazeneca Medison MSD Novartis Pfizer Teva Silver Sponsor Bayer BMS Boehringer-Ingelheim Eli Lilly Janssen Merck Serono Nanostring technologies Bronze Sponsor Astellas CancerHope Champions Oncology Ferring GSK ISI Mediline Neopharm RAFA Sanofi Scientific Committe ISCORT 14 Organizing Company I.M. Knasim Ltd. פרופ' רון אפלבוים:נשיא הכנס ד"ר רוית גבע:מזכירת הכנס ISCORT 14 Prof. David Geffen, Chairman Prof. Shmuel Ariad Dr. Gil Bar-Sela Prof. Baruch Brenner Prof. Jacob Gopas Prof. Nissim Haim Dr. Rinat Yerushalmi Dr. Yaacov Lawrence Prof. Michal Lotem Dr. Rafi Pfeffer Prof. Benjamin Corn Dr. Eli Rosenbaum Prof. Salomon Stemmer הוועדה המארגנת הוועדה המדעית יו"ר,פרופ' דוד גפן פרופ' שמואל אריעד דר' גיל בר סלע פרופ' ברוך ברנר )פרופ' יעקב גופס (מדעי יסוד פרופ' נסים חיים דר' רינת ירושלמי דר' יעקב לורנס פרופ' מיכל לוטם דר' רפאל פפר פרופ' בנימין קורן דר' אלי רוזנבאום פרופ' סלומון שטמר החברה המארגנת כנסים בע"מ.מ.א Dear Friends, Welcome to ISCORT 14, the 14th Annual Conference of the Israeli Society for Clinical Oncology and Radiation Therapy, being held in Eilat on January 27-31, 2015. In recent years, developments and innovations in cancer research and treatment have been quick and major. The present conference gives us the opportunity to be updated on the great progress that occurred in clinical oncology, radiotherapy, and cancer basic research. This conference, with the participation of leading experts from Israel and abroad, includes three main sessions on lung cancer, gastrointestinal cancer and breast cancer, a fourth session will cover other tumors. Additional sessions will focus on innovations in genomics, immunotherapy and radiotherapy. The familiar lecture format will be joined by clinical discussions in the form of tumor boards and debates. It will be interesting! We would specifically like to draw your attention to the three keynote lectures given on the first and last days of the conference, and to the open discussions on Friday discussing two important and “hot” topics related to oncological activity in Israel. We consider ISCORT as an important platform for presenting the original clinical and basic science studies of its members. A unique session will present the three research proposals competing for the ISCORT Research Grant. The choice of the winner is largely in your hands, so your presence is important, as each vote can influence the result. The Scientific Committee, headed by Prof. David Geffen, chose the best scientific work in the field of oncology in Israel. We would like to express our deep appreciation and gratitude for their excellent and devoted work. We hope you will enjoy the rich and varied professional program, and also the social and cultural atmosphere around. And, yes, have some rest too. ,חברים יקרים עשר של האיגוד הישראלי- הכינוס השנתי הארבעה,ISCORT 14 ברוכים הבאים לכנס .2015 בינואר27-31 שמתקיים באילת בין התאריכים,לאונקולוגיה קלינית ורדיותרפיה ההתפתחויות והחידושים בחקר הסרטן ובטיפול בו בשנים האחרונות מהירים ביותר הכנס הנוכחי נותן לנו הזדמנות להתעדכן אודות ההתקדמות.וגדולים בהיקפם כמו גם,הרבה שחלה בתחומים השונים של האונקולוגיה הקלינית והרדיותרפיה .במחקר הבסיסי הרלבנטי בנוי בצורת, ובו משתתפים מומחים מובילים בתחומם מהארץ ומהעולם,הכנס מערכת, שלשה מושבים עיקריים ידונו בהתפתחויות בנושאי סרטן הריאה.מושבים בנוסף יתקיימו מושבים. ומושב רביעי עוסק בגידולים שונים אחרים,העיכול והשד " בכנס זה אנו "מתבלים. אימונותרפיה ורדיותרפיה,שיתמקדו בחידושים בגנומיקה tumor boards את פורמט ההרצאות המוכר והטוב בדיונים קליניים בצורת ! יהיה מעניין.debates-ו שתינתנה בימיםkeynote lectures-אנו רוצים לציין באופן מיוחד את שלושת ה וכן את הדיונים ביום שישי שבהם תוכלו להתווכח ולהביע,הראשון והאחרון של הכנס ."חמות" הקשורות בפעילות האונקולוגית בארץ- סוגיות חשובות ו2-דעה ב אנו רואים בכנס האונקולוגי השנתי במה חשובה להצגת העבודות המקוריות הקליניות אלו שולבו במושבים השונים ע"פ הנושאים הנידונים.והמחקריות של חברי האיגוד הצעות המחקר שנבחרו להשתתף3- בנוסף יש מושב מיוחד בו נתוודע ל.בהם הבחירה בהצעה המנצחת היא בעיקרה.בתחרות על מענק המחקר של האיגוד .בידיכם ועל כן נוכחותכם חשובה וכל קול קובע הוועדה המדעית ברשותו של פרופ' דוד גפן שבחרה את מיטב היצירה המדעית ועל כך יבואו,בארץ בתחום האונקולוגיה עשתה עבודתה במסירות ובמקצועיות רבה .חברי הוועדה על הברכה והתודה ובנוסף תזכו,אנו מקווים שתיהנו מהתכנית המקצועית העשירה והמגוונת של הכנס ... גם לקצת מנוחה, וכן,להנאה חברתית ותרבותית בשהייתכם כאן Sincerely, Prof. Ron Epelbaum ISCORT 14, President ,בברכה Dr. Ravit Geva ISCORT 14, Secretary ד"ר רוית גבע ISCORT 14 ,מזכירת הכנס פרופ' רון אפלבוים ISCORT 14 ,נשיא הכנס Tuesday, January 27, 2015 17:00-17:20 17:20-18:05 17:25-17:35 17:35-17:45 17:45-17:55 Opening ceremony Greetings and best residents award Moderator: Dr. Ravit Geva, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Speakers: Dr. Wilmosh Mermershtain, ISCORT President, Soroka Medical Center, Beer-Sheva, Israel Mrs. Miri Ziv, CEO, Israel Cancer Association, Givataym, Israel Prof. Ron Epelbaum, Conference President, Rambam Health Care Campus, Haifa, Israel The best of ISCORT Moderators: Prof. David Geffen, Soroka Medical Center, Beer-Sheva, Israel Prof. Nissim Haim, Rambam Health Care Campus, Haifa, Israel Abstract # 1304 A phase I study of mitomycin-C prodrug in pegylated liposomes Prof. Alberto Gabizon, Shaare Zedek, Jerusalem, Israel Abstract # 903 Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer Dr. Ido Wolf, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Abstract # 316 Early detection of lung cancer (LCD) by fishbased sputum test Prof. Nir Peled, Rabin Medical Center, Petach-Tikva, Israel 17:55-18:05 Discussion Prof. David Geffen, Soroka Medical Center, Beer-Sheva, Israel 18:05-19:15 Keynote lectures Moderators: Dr. Ravit Geva, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Prof. Ron Epelbaum, Rambam Health Care Campus, Haifa, Israel 18:05-18:30 Cancer Prevention Prof. Nadir Arber, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Supported by ISCORT 18:30-19:15 The wisdom of the crowd: From Bacteria to the cyberwar between cancer and the immune system Prof. Eshel Ben-Jacob, Tel Aviv University, Tel-Aviv, Israel Supported by Merck Serono 19:30-21:00 Dinner Wednesday, January 28, 2015 08:00-10:00 Lung Cancer - Part I 08:00-09:05 Moderators: Dr. Jair Bar, Sheba Medical Center, Ramat-Gan, Israel Prof. Shmuel Ariad, Soroka Medical Center, Beer-Sheva, Israel 08:00-08:20 Lung cancer in Israel: Data from the Israel National Cancer Registry Dr. Barbara Silverman, Israel National Cancer Registry, Israel Supported by Roche 08:20-08:30 08:30-09:05 Advanced squamous cell lung cancer the past, present and near future Dr. Abed Agbarya, Assuta Medical Center, Haifa, Israel Invited session, Supported by Lilly Educational New horizons in advanced squamous cell lung cancer treatment: Squire and Revel trials Prof. Nick Thatcher, University of Manchester, UK Supported by Lilly 09:10-10:00 Moderator: Prof. Hovav Nechushtan, Hadassah Hebrew University Medical Center, Jerusalem, Israel 09:10-09:35 The evolving treatment paradigm in adenocarcinoma of the lung Dr. Natalie Maimon-Rabinovich, Meir Medical Center, Kfar-Saba, Israel Supported by Roche 09:35-10:00 Targeting angiogenesis in NSCLC Dr. Maya Gottfried, Meir Medical Center, Kfar-Saba, Israel Supported by BI 10:00-10:30 Coffee Break 10:30-13:00 Lung Cancer - Part II 10:30-11:20 Moderator: Prof. Ofer Merimsky, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 10:30-10:55 EML4 - ALK positive lung cancer, 1st line therapy and beyond Prof. Nir Peled, Rabin Medical Center, Petach-Tikva, Israel Supported by Pfizer 10:55 -11:20 Evolving treatment paradigms for NSCLC treatment resistances Dr. Dov Hershkovitz, Rambam Health Care Campus, Haifa, Israel Supported by Astrazeneca 11:20-12:20 12:20-13:00 12:20-12:30 Tumor board - Lung cancer Moderator: Dr. Maya Gottfried, Meir Medical Center, Kfar-Saba, Israel Panel: Dr. Alon Aharon, Rabin Medical Center, Petach-Tikva, Israel Prof. Rivka Zissin, Meir Medical Center, Kfar-Saba, Israel Dr. Alon Ben Nun, Sheba Medical Center, Israel Prof. Ofer Merimsky, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Top lung cancer abstracts Moderators: Dr. Shoshana Keren, Lin Medical Center, Haifa, Israel Dr. Julia Dudnik, Soroka Medical Center, Beer-Sheva, Israel Abstract # 318 Oral glucose tolerance test as a breath challenge diagnostic test in lung cancer Dr. Layah Alkoby, Sheba Medical Center, Ramat-Gan, Israel Wednesday, January 28, 2015 (Continued) 12:30-12:40 12:40-12:50 Abstract # 309 A prospective, open-label, multi-center, single-arm study investigating the correlation between erlotinib induced rash and efficacy in epidermal growth factor receptor (EGFR) Mutated advanced non-small cell lung cancer (NSCLC) patients receiving first-line therapy Dr. Maya Gottfried, Meir Medical Center, Kfar-Saba, Israel Abstract # 312 Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients Prof. Nissim Haim, Rambam Health Care Campus, Haifa, Israel 13:00-14:00 Lunch 14:00-16:00 Immunotherapy 14:00-14:45 Educational Immunotherapy - A new era in cancer treatment Prof. Tanguy Seiwert, University of Chicago, USA Supported by MSD 14:45-15:10 Immunotherapy - The modern approach to the treatment of melanoma Prof. Jacob Schachter, Sheba Medical Center, Ramat-Gan, Israel Supported by BMS Moderators: Prof. Jacob Schachter, Sheba Medical Center, Ramat-Gan, Israel Dr. Orit Gotfeld, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 15:10-15:35 Anti-PD1 in H&N cancer Prof. Tanguy Seiwert, University of Chicago, USA Supported by MSD 15:35-16:00 Advances in Immunotherapy for the treatment of lung cancer Dr. Jair Bar, Sheba Medical Center, Ramat-Gan, Israel Supported by Roche 16:00-16:30 Coffee Break 16:30-18:15 Additional tumors (But not less important…) 16:30-17:45 Moderators: Dr. Safra Tamar, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Dr. Eli Rosenbaum, Rabin Medical Center, Petach-Tikva, Israel 16:30-16:55 Identifying the appropriate treatment for locally advance BCC patients: A multidisciplinary team approach Prof. Eyal Fenig, Rabin Medical Center, Petach-Tikva, Israel Prof. Yosef Elkalay, Assuta Medical Center, Tel-Aviv, Israel Supported by Roche 16:55-17:20 Treatment approaches for cervical cancer Prof. Tally Levy, Wolfson Medical Center, Holon, Israel Supported by Roche 17:20-17:45 Precision medicine for prostate cancer: Transitioning from drug to therapy development Prof. Eleni Efstathiou, M.D. Anderson Cancer Center, Houston, USA Supported by Janssen Wednesday, January 28, 2015 (Continued) Thursday, January 29, 2015 17:45-18:15 Top additional tumors abstracts - Part I Moderators: Prof. Avishay Sella, Assaf Harofeh Medical Center, Zerifin, Israel Dr. Ronnie Shapira, Sheba Medical Center, Ramat-Gan, Israel 08:00-10:30 Breast Cancer 08:00-08:50 Moderator: Dr. Rinat Yerushalmi, Rabin Medical Center, Petach-Tikva, Israel 17:45-17:55 Abstract # 1301 The aging suppressor hormone klotho: A novel tumor suppressor and regulator of IGF-1 and estrogen signaling in ovarian cancer Dr. Ido Wolf, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 08:00-08:25 CDK 4/6 Inhibition - New mechanism, new hope Prof. Bella Kaufman, Sheba Medical Center, Ramat-Gan, Israel Supported by Pfizer 08:25-08:50 New and evolving treatments for HER2+ breast cancer: Raising The Bar Prof. Hope Rugo, University of California, San Francisco, USA Supported by Roche 17:55-18:05 18:05-18:15 Abstract # 403 Patients with the rare subtype of metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (TX): Results from a Large International Metastatic RCC Database Dr. Daniel Keizman, Meir Medical Center, Kfar-Saba, Israel Abstract # 409 A single-arm, multicenter, open-label phase II trial of cabazitaxel as second-line treatment for patients with locally advanced or metastatic transitional cell carcinoma (TCC) Dr. Avivit Peer, Rambam Health Care Campus, Haifa, Israel 19:00-21:00 Dinner 21:00 Social Event 08:50-09:50 09:50-10:30 Tumor board - Breast cancer Moderator: Dr. Noa Ben-Baruch, Kaplan Medical Center, Rehovot, Israel Panel: Prof. Moshe Inbar, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Dr. Merav Ben-David, Sheba Medcial Center, Ramat-Gan, Israel Dr. Yuliana Weinstein, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Dr. Tanir Allweis, Kaplan Medical Center, Rehovot, Israel Top Breast cancer abstracts Moderators: Dr. Larisa Ryvo, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Dr. Karen Drumea, Rambam Health Care Campus, Haifa, Israel Wednesday, Thursday, January January 29,28, 2015 2015 (Continued) (Continued) 09:50-10:00 10:00-10:10 10:10-10:20 Abstract # 7 Ten-year analyses of the big 2-98 phase III Trial with pooled analysis on the role of KI67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer Dr. Amir Sonnenblick, Institute Jules Bordet, Bruxelles, Belgium Abstract # 901 The role of breast cancer cell microparticles in thrombogenicity, angiogenesis and apoptosis following chemotherapy Dr. Gil Bar-Sela, Rambam Health Care Campus, Haifa, Israel Abstract # 9 Earlier age of breast cancer onset in Israeli BRCA carriers-anticipation or selection bias effect Dr. Rinat Yerushalmi, Rabin Medical Center, Petach-Tikva, Israel 10:30-11:00 Coffee break 11:00-13:30 Genomics (Parallel Session I - Main Hall) 11:00-13:00 Moderators: Prof. Bella Kaufman, Sheba Medical Center, Ramat-Gan, Israel Prof. Ilan Ron, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 11:00-11:45 Educational Clinical implications of intrinsic molecular subtypes of cancer Dr. Aleix Prat, Hospital Clinic De Barcelona, Barcelona, Spain Supported by Nanostring 11:45-12:10 12:10-12:35 12:35-13:00 13:00-13:30 13:00-13:15 13:15-13:30 11:00-13:30 11:00-11:05 11:05-11:30 Genetic alterations and management of ALK+ in NSCLC Dr. Enriqueta Felip, Vall d’Hebron University Hospital, Barcelona, Spain Supported by Novartis Molecular diagnostics and treatment practices from EGFR and KRAS to NGS panels and germline mutations in BRCA Prof. Gad Rennert, Carmel Medical Center, Haifa, Israel Supported by Astrazeneca The role of molecular profiling for patients with ductal carcinoma in situ (DCIS) of the breast Prof. Lawrence J. Solin, MD, FACR, FASTRO, University of Pensylvania, Philadelphia, PA. USA Supported by Teva Moderator: Dr. Asher Shalmon Hadassah Hebrew University Medical Center, Jerusalem, Israel Genetics subtypes in colon cancer - Are we really there? Prof. Dan Aderka, Sheba Medical Center, Ramat-Gan, Israel Is proteomics the new genomics? Dr. Ido Wolf, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Radiotherapy (Parallel Session II - Tarshish Hall, 1st floor) Greetings Dr. Rafi Pfeffer, Assuta Medical Center, Tel-Aviv, Israel Moderator: Dr. Zvi Symon, Sheba Medial Center, Ramat-Gan, Israel Reviewing the TARGIT Trial of intra-operative radiotherapy for early breast cancer - latest results, patient selection and indications for treatment Prof. Jeffrey S Tobias, University College London, London, UK Supported by Medison Wednesday, Thursday, January January 29,28, 2015 2015 (Continued) (Continued) 12:50-13:00 11:30-12:00 Moderator: Dr. Rafi Pfeffer, Assuta Medical Center, Tel-Aviv, Israel Radiation dose escalation in locally advanced NSCLC: Back to the past? Dr. Benjamin Movsas, Henry Ford Hospital, Detroit, Michigan, USA Moderator: Dr. Amichay Meirovitz, Hadassah Hebrew University Medical Center, Jerusalem, Israel Advances in radiotherapy for unresectable pancreatic cancer Prof. Edgar Ben-Josef, University of Pennsylvania, Philadelphia, USA 12:00-12:20 12:20-12:40 12:40-13:30 12:40-12:50 Moderator: Dr. Gideon Marshak, Clalit Health Services, Tel-Aviv, Israel Head and neck radiation technology: Where are we going? Dr. Salem Billan, Rambam Health Care Campus, Haifa, Israel Top radiotherapy abstracts Moderators: Prof. Rami Ben-Yosef, Rambam Health Care Campus, Haifa, Israel Prof. Eyal Fenig, Rabin Medical Center, Petach-Tikva, Israel Abstract # 1005 The first reported use of continuous positive airway pressure (CPAP) in patients receiving stereotactic body radiation therapy (SBRT): A prospective trial studying the effect on tumor motion and dose to critical organs Dr. Sarit Appel, Sheba Medical Center, Ramat-Gan, Israel 13:00-13:10 13:10-13:20 Abstract # 1009 Image guided radiation therapy (IGRT) reduces gastrointestinal (GI) and genitourinary (GU) toxicity when radiating the prostate fossa (PF) Dr. Benjamin Spieler, Sheba Medical Center, Ramat-Gan, Israel Abstract # 1010 Actively targeted gold nanoparticles as novel radiosensitizer agents: In vivo head and neck cancer model Dr. Aharon Popovtzer, Rabin Medical Center, Petach-Tikva, Israel Abstract # 313 Stereotactic radiotherapy (SBRT) in the treatment of centrally located tumors, a single institution experience Dr. Yasmin Korzets-Ceder, Rabin Medical Center, Petach-Tikva, Israel 13:30-14:30 Lunch Conference will convene at Tarshish Hall, 1st floor 14:30-16:30 GI Malignancies - Part I 14:30-14:55 Moderator: Dr. Efraim Idelevich, Kaplan Medical Center, Rehovot, Israel Treatment of CRC in 2015: Daily practice dilemmas and potential pitfalls Prof. Baruch Brenner, Rabin Medical Center, Petach-Tikva, Israel Supported by Roche Wednesday, Thursday, January January 29,28, 2015 2015 (Continued) (Continued) 16:10-16:20 14:55-15:30 Debate – It’s time for chemotherapy alone in the neoadjuvant treatment of rectal cancer Moderators: Prof. Aharon Sulkes, Rabin Medical Center, Petach-Tikva, Israel Prof. Adi Shani, Sheba Medical Center, Ramat-Gan, Israel 14:55-15:05 Pro: Dr. Alex Benny, Rambam Health Care Campus, Haifa, Israel 15:05-15:15 Con: Dr. Marc Wygoda, Hadassah Hebrew University Medical Center, Jerusalem, Israel 15:15-15:30 Open Discussion 15:30-16:00 Moderator: Dr. Sofia Man, Soroka Medical Center, Beer-Sheva, Israel 15:30-15:45 Major dilemmas in the management of pancreatic cancer Dr. Ravit Geva, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 15:45-16:00 Major dilemmas in the management of gastric cancer Dr. Yakterina Shulman, Hillel Yaffe Medical Center, Hadera, Israel 16:00-16:30 Top GI malignancies abstracts Moderators: Dr. Thomas Tishler, Shaare Zedek, Jerusalem, Israel Dr. Alexander Gluzman, Soroka Medical Center, Beer-Sheva, Israel 16:00-16:10 Abstract # 211 CD24 and APC genetic polymorphisms in pancreatic cancers – Do they have a role as biomarkers for clinical outcome? Dr. Sivan Shamai, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 16:20-16:30 Abstract # 209 Colorectal cancer in young patients: A distinct clinical entity or not? Dr. Hadar Goldvaser, Rabin Medical Center, Petach-Tikva, Israel Abstract # 212 Genetic features of lynch syndrome in the israeli population Dr. Yael Goldberg, Hadassah Hebrew University Medical Center, Jerusalem, Israel 16:30-17:00 Coffee break 17:00-18:00 GI Malignancies - Part II 17:00-18:00 Tumor board - Focus on GI malignancies liver spread Moderator: Dr. Ayala Hubert, Hadassah Hebrew University Medical Center, Jerusalem, Israel Panel: Prof. Arie Blachar, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Dr. Ido Nachmani, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Dr. Yaacov Lawrence, Sheba Medical Center, Ramat-Gan, Israel Prof. Baruch Brenner, Rabin Medical Center, Petach-Tikva, Israel 18:00-18:25 Moderator: Prof. Baruch Klein, Assuta Medical Center, Tel-Aviv, Israel The integration of SIRT into the treatment of inoperable liver tumors Dr. Gianluca Masi, University of Pisa, Italy Supported by Medison 19:00-21:00 Dinner 21:00 Social Event Friday, January 30, 2015 08:00-08:30 Best grant proposal competition 08:00-08:30 Moderator: Dr. Raanan Berger, Sheba Medical Center, Ramat-Gan, Israel Panel: Prof. David Geffen, Soroka Medical Center, Beer-Sheva, Israel Prof. Hovav Nechushtan, Hadassah Hebrew University Medical Center, Jerusalem, Israel Dr. Asher Shalmon, Hadassah Hebrew University Medical Center, Jerusalem, Israel 08:05-08:10 Update from last year’s winner Dr. Valeria Semenisty, Rambam Health Care Campus, Haifa, Israel 08:10-08:15 Minimally invasive screening approach for early detection of ovarian cancer Dr. Keren Levanon, Sheba Medical Center, Ramat-Gan, Israel 08:15-08:20 08:20-08:25 Attitudes of oncologic patients towards partecipation in clinical trials Dr. Nethanel Asher Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel The contribution of host response to chemotherapy-induced lymphangiogenesis and its role in the clinical setting Dr. Orit Kaidar–Person, Rambam Health Care Campus, Haifa, Israel 08:25-08:30 Vote and award best grant proposal award 08:30-08:35 Best published paper award 2014 Moderator: Prof. David Geffen, Soroka Medical Center, Beer-Sheva, Israel 08:35-09:05 09:05-10:05 09:05-09:45 09:05-09:20 09:20-09:45 09:45-10:05 09:45-09:55 09:55-10:05 10:05-10:30 10:30-11:00 Keynote lecture Moderator: Dr. Rafi Pfeffer, Assuta Medical Center,Tel-Aviv, Israel The emerging role of SBRT for oligometastases Prof. Benjamin Movsas, Henry Ford Hospital, Detroit, Michigan, USA Supportive Care Moderator: Dr. Yaacov Baram, The Baruch Padeh Medical Center, Poriya, Tiberias, Israel Palliative care expertise: should the oncologist care? Dr. Gil Bar-Sela, Rambam Health Care Campus, Haifa, Israel Rapid-onset opiates: Sophisticated drug delivery to control breakthrough pain Dr. Daniel Kurnik, Rambam Health Care Campus, Haifa, Israel Supported by Teva Top Supportive care abstracts Moderator: Dr. Menachem Ben-Shahar, Nahariya medical center, Nahariya, Israel Abstract # 1104 Spiritual support amongst Israeli oncology patients Dr. Yasmin Natan-Oz, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Abstract # 1101 The association between working alliance and type of concerns, shared by advanced cancer patients during chemotherapy Dr. Gil Bar-Sela, Rambam Health Care Campus, Haifa, Israel Coffee break Top additional tumors abstracts - Part II Moderators: Prof. Michal Lotem, Hadassah Hebrew University Medical Center, Jerusalem, Israel Dr. Noam Asna, Barzilai Medical Center, Ashkelon, Israel Wednesday, Friday, January January 30, 2015 28, 2015 (Continued) (Continued) 10:30-10:40 10:40-10:50 10:50-11:00 11:00-11:15 11:15-12:35 11:15-11:55 11:15-11:25 11:25-11:35 Abstract # 909 Next generation sequencing (NGS) in soft tissue sarcoma (STS) patients in israel Dr. Sivan Shamai, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Abstract # 1303 Advances in the management of hepatocellular carcinoma patients lead to improved survival Dr. Assaf Moore, Rabin Medical Center, Petach-Tikva, Israel Abstract # 801 Loss of ADAR1 is pivotal in the development of metastatic melanoma Dr. Gal Markel, Sheba Medical Center, Ramat-Gan, Israel Geriatric oncology Moderator: Prof. Yoram Cohen, Ben-Gurion University of the Negev, Beer-Sheva, Israel Discussion on the recommendations of the geriatric oncology national committee Prof.Salomon Stemmer, Rabin Medical Center, Petach-Tikva, Israel Debates in current oncology Debate I Should we perticipate in public advertising of cancer drugs, will we be held accountable? Moderator: Prof. Abraham Kuten, Italian Hospital, Haifa, Israel Pro: Dr. Raanan Berger, Sheba Medical Center, Ramat-Gan, Israel Con: Dr. Wilmosh Mermershtain, Soroka Medical Center, Beer-Sheva, Israel 11:35-11:55 Open discussion 11:55-12:35 Debate II Should radiotherapy and medical oncology finally part as friends? Moderator: Prof. Raphael Catane Sheba Medical Center, Ramat-Gan, Israel 11:55-12:05 Pro: Dr. Zvi Symon, Sheba Medical Center, Ramat-Gan, Israel 12:05-12:15 Con: Prof. Beatrice Uziely, Hadassah Hebrew University Medical Center, Jerusalem, Israel 12:15-12:35 12:35-12:50 Open discussion Regional collaborations Moderator: Prof. Eli Gez, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel The importance of regional collaborations in oncology Prof. Dr. Serdar Turhal, Anadolu Medical Center, Istanbul, Turkey 12:50-13:00 Closing remarks 13:00-14:00 Lunch 14:00-15:00 ISCORT Assembly 19:00-21:00 Dinner 21:00 Social event Prof. Ron Epelbaum, Conference President, Rambam Health Care Campus, Haifa, Israel Saturday, January 31, 2015 07:30-10:00 Breakfast 13:00-14:30 Lunch 16:00 Checkout This programm was printed with the support of Roche Pharmaceuticals (Israel) Ltd.
© Copyright 2024